PW Medtech Group Limited (HKG:1358)
1.020
+0.010 (0.99%)
At close: Mar 27, 2026
PW Medtech Group Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,803 | 1,682 | 1,590 | 1,382 | 2,285 |
Trading Asset Securities | 5 | 5.15 | 4.9 | 5.63 | 127 |
Cash & Short-Term Investments | 1,808 | 1,687 | 1,595 | 1,388 | 2,412 |
Cash Growth | 7.16% | 5.81% | 14.92% | -42.47% | 41.72% |
Accounts Receivable | 168.14 | 92.9 | 109.72 | 89.25 | 90.67 |
Other Receivables | - | 51.53 | 55.17 | 51.02 | 48.54 |
Receivables | 408.14 | 264.42 | 284.88 | 406.57 | 139.21 |
Inventory | 145.2 | 120.28 | 136.61 | 132.23 | 33.18 |
Other Current Assets | - | 22.4 | 15.54 | 19.76 | 9.12 |
Total Current Assets | 2,361 | 2,094 | 2,032 | 1,946 | 2,593 |
Property, Plant & Equipment | 935.5 | 922.02 | 933.01 | 958.64 | 627.74 |
Long-Term Investments | - | 46.54 | 61.28 | 90.33 | 10 |
Goodwill | 564.09 | 564.09 | 564.09 | 564.09 | 160.75 |
Other Intangible Assets | 1,018 | 1,018 | 363.05 | 393.12 | 13.93 |
Long-Term Accounts Receivable | - | - | - | 6.9 | - |
Long-Term Deferred Tax Assets | 9.82 | 10.13 | 10.29 | 23.02 | 23.33 |
Long-Term Deferred Charges | - | 50.53 | 733.94 | 699.33 | - |
Other Long-Term Assets | 346.27 | 275.61 | 274.82 | 307.6 | 306 |
Total Assets | 5,235 | 5,161 | 5,152 | 4,989 | 3,915 |
Accounts Payable | 154.97 | 41.79 | 36.79 | 27.84 | 10.58 |
Accrued Expenses | - | 57.47 | 47.73 | 55.57 | 36.58 |
Short-Term Debt | 15 | - | - | - | - |
Current Portion of Leases | 2.25 | 1.7 | 0.76 | 3.11 | 2.44 |
Current Income Taxes Payable | 14.54 | 17.04 | 10.66 | 26.59 | 5.56 |
Current Unearned Revenue | 30.04 | 21.09 | 8.89 | 13.59 | 0.64 |
Other Current Liabilities | - | 38.36 | 44.44 | 41.14 | 48.68 |
Total Current Liabilities | 216.8 | 177.44 | 149.26 | 167.85 | 104.47 |
Long-Term Debt | - | 5.8 | - | - | - |
Long-Term Leases | 4.75 | 4.58 | 0.37 | 1.13 | - |
Long-Term Unearned Revenue | 20.86 | 21.31 | 22.72 | 23.11 | 16.01 |
Long-Term Deferred Tax Liabilities | 139.11 | 148.44 | 154.71 | 159.47 | 2.16 |
Total Liabilities | 381.52 | 357.56 | 327.06 | 351.56 | 122.64 |
Common Stock | 0.9 | 0.94 | 0.96 | 0.96 | 0.97 |
Additional Paid-In Capital | 1,393 | 1,410 | 1,490 | 1,490 | 1,493 |
Retained Earnings | 2,141 | 2,177 | 2,161 | 2,026 | 1,920 |
Treasury Stock | -2.75 | - | - | - | - |
Comprehensive Income & Other | 418.45 | 383.64 | 392.77 | 428.84 | 378.98 |
Total Common Equity | 3,950 | 3,971 | 4,044 | 3,945 | 3,792 |
Minority Interest | 903.26 | 831.97 | 780.64 | 692.33 | - |
Shareholders' Equity | 4,854 | 4,803 | 4,825 | 4,638 | 3,792 |
Total Liabilities & Equity | 5,235 | 5,161 | 5,152 | 4,989 | 3,915 |
Total Debt | 22 | 12.07 | 1.13 | 4.24 | 2.44 |
Net Cash (Debt) | 1,786 | 1,675 | 1,593 | 1,383 | 2,409 |
Net Cash Growth | 6.61% | 5.12% | 15.19% | -42.59% | 44.16% |
Net Cash Per Share | 1.18 | 1.09 | 1.02 | 0.88 | 1.54 |
Filing Date Shares Outstanding | 1,533 | 1,487 | 1,566 | 1,566 | 1,569 |
Total Common Shares Outstanding | 1,533 | 1,487 | 1,566 | 1,566 | 1,569 |
Working Capital | 2,144 | 1,917 | 1,882 | 1,778 | 2,489 |
Book Value Per Share | 2.58 | 2.67 | 2.58 | 2.52 | 2.42 |
Tangible Book Value | 2,368 | 2,390 | 3,117 | 2,988 | 3,618 |
Tangible Book Value Per Share | 1.54 | 1.61 | 1.99 | 1.91 | 2.31 |
Buildings | - | 663.18 | 643.81 | 637.14 | 520.34 |
Machinery | - | 456.6 | 411.49 | 359.46 | 112.77 |
Construction In Progress | - | 100.22 | 143.77 | 162.31 | 93.53 |
Leasehold Improvements | - | 67.78 | 35.28 | 32.89 | 8.79 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.